Locally advanced non-metastatic pancreatic cancer--can we do more?

Locally advanced non-metastatic pancreatic cancer--can we do more?

Detalles Bibliográficos
Main Authors:	Hawkins, M, Tait, D
Formato:	Journal article
Idioma:	English
Publicado:	2008

Títulos similares

Dose escalation for locally advanced pancreatic cancer: How high can we go?
por: Lauren E. Colbert, MD, et al.
Publicado: (2018-10-01)

Metastatic Pancreatic Cancer: Where Are We?
por: Abraham Hernández-Blanquisett, et al.
Publicado: (2024-01-01)

Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer.
por: Mukherjee, S, et al.
Publicado: (2008)

We Can Do More
por: Howard Adelman
Publicado: (1992-09-01)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
por: Borghesi, S, et al.
Publicado: (2008)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
por: Borghesi, S, et al.
Publicado: (2008)

What Do We Mean When We Ask for More Metastatic Breast Cancer Research?
por: Kimberly Badovinac, et al.
Publicado: (2021-07-01)

Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
por: L. I. Moskvicheva, et al.
Publicado: (2020-12-01)

Metastatic Pancreatic Cancer: Are We Making Progress in Treatment?
por: Joanne Chiu, et al.
Publicado: (2012-01-01)

653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)
por: Francesca Barone, et al.
Publicado: (2023-11-01)

Desmoplasia in Pancreatic Cancer. Can We Fight It?
por: E. E. Merika, et al.
Publicado: (2012-01-01)

Do we see more than we can access?
por: Siegel, Susanna, et al.
Publicado: (2010)

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer
por: Mengjiao Fan, et al.
Publicado: (2024-01-01)

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer erbitux, radiotherapy and UFT (PERU) trial.
por: Khan, K, et al.
Publicado: (2016)

Mother's milk: What more can we do?
por: Giuseppe Buonocore
Publicado: (2024-03-01)

Low vision: we can all do more
por: Hasan Minto, et al.
Publicado: (2012-01-01)

The Advancement to the Circular Economy. Where We Are and What We Can Do at Local/Regional Level
por: Angela ALBU
Publicado: (2023-06-01)

Locally Advanced and Metastatic Pancreatic Cancer: Survival analysis and prognostic factors in a case series
por: Paloma Porto Amorim, et al.
Publicado: (2020-01-01)

Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
por: G. C. Deng, et al.
Publicado: (2021-11-01)

Biomarkers in metastatic melanoma of the skin: can we more accurately choose the tactics of treating our patients?
por: A. R. Zaretsky, et al.
Publicado: (2021-08-01)

Can we do more to get patients to cholesterol targets?
por: Hobbs, R
Publicado: (2002)

Plastic pollution: What have we done? What more can we do?
por: Haoxuan Yu, et al.
Publicado: (2024-11-01)

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
por: Virdee, P, et al.
Publicado: (2017)

Metastatic Pancreatic Cancer
por: Piotr Hogendorf, et al.
Publicado: (2018-03-01)

On-going technical advances, can we use them to deliver more personalised medicine?
por: Simon de Lusignan
Publicado: (2011-05-01)

THE POSSIBILITIES OF MODERN METHODS OF ABLATION IN NON-RESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
por: L. I. Moskvicheva, et al.
Publicado: (2018-06-01)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
por: Anthony Turpin, et al.
Publicado: (2022-09-01)

We are more than others can say
por: David Steare
Publicado: (2022-04-01)

Is remnant pancreatic cancer after pancreatic resection more frequent in early‐stage pancreatic cancer than in advanced‐stage cancer?
por: Yoshihiro Miyasaka, et al.
Publicado: (2020-07-01)

P-233: SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
por: Virdee, P, et al.
Publicado: (2017)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
por: Ma Yue, et al.
Publicado: (2011-03-01)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
por: Holyoake, DLP, et al.
Publicado: (2018)

How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?
por: Jeonghee Han
Publicado: (2023-12-01)

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
por: J Greenhalgh, et al.
Publicado: (2010-10-01)

Why do we know so little about refugees? How can we learn more?
por: Jeff Crisp
Publicado: (2003-09-01)

Recurrent respiratory infection protection in children: can we do anything more?
por: article Editorial
Publicado: (2020-03-01)

Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients
por: Alessandro Bittoni, et al.
Publicado: (2021-09-01)

Cisplatin and vinorelbine in the treatment of locally advanced and metastatic non-small cell lung cancer
por: Wong, Catherine Mee Ming, et al.
Publicado: (2001)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
por: Zhang S, et al.
Publicado: (2018-11-01)

“Can’t We Talk About Something More Pleasant”
por: Randi Belisomo
Publicado: (2014-07-01)